Carosella, 1999, A tolerance molecule from the major histocompatibility complex, Immun. Today, 20, 60, 10.1016/S0167-5699(98)01387-5
Le Bouteiller, 1999, The functionality of HLA-G is emerging, Immunol Rev, 167, 233, 10.1111/j.1600-065X.1999.tb01396.x
Rouas-Freiss, 1997, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proc Natl Acad Sci USA, 94, 11520, 10.1073/pnas.94.21.11520
Wei, 1990, Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissues, Hum Immunol, 29, 131, 10.1016/0198-8859(90)90076-2
Lee, 1995, The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association, Immunity, 3, 591, 10.1016/1074-7613(95)90130-2
Diehl, 1996, Nonclassical HLA-G molecules are classical peptide presenters, Curr Biol, 6, 305, 10.1016/S0960-9822(02)00481-5
Lee, 1998, HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences, J Immunol, 160, 4951, 10.4049/jimmunol.160.10.4951
Braud, 1999, Functions of nonclassical MHC and non-MHC-encoded class I molecules, Curr Opin Immunol, 11, 100, 10.1016/S0952-7915(99)80018-1
Tomasec, 2000, Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40, Science, 287, 1031, 10.1126/science.287.5455.1031
Llano, 1998, HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors, Eur J Immunol, 28, 2854, 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W
Wainwright, 2000, HLA-F is a predominantly empty, intracellular, TAP-associated MHC Class Ib protein with a restricted expression pattern, J Immunol, 164, 319, 10.4049/jimmunol.164.1.319
Geraghty, 1992, Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes, Proc Natl Acad Sci USA, 89, 2669, 10.1073/pnas.89.7.2669
Fujii, 1994, A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4, J Immunol, 153, 5516, 10.4049/jimmunol.153.12.5516
Ishitani, 1992, Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens, Proc Natl Acad Sci USA, 89, 3947, 10.1073/pnas.89.9.3947
Kirszenbaum, 1994, An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes, Proc Natl Acad Sci USA, 91, 4209, 10.1073/pnas.91.10.4209
Moreau, 1995, Soluble HLA-G molecule, Hum Immunol, 43, 231, 10.1016/0198-8859(95)00009-S
Rouas-Freiss, 1997, The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells, Proc Natl Acad Sci USA, 94, 5249, 10.1073/pnas.94.10.5249
Allan, 1999, Tetrameric complexes of human histocompatibility leukocyte antigen (HLA-G) bind to peripheral blood myelomonocytic cells, J Exp Med, 189, 1149, 10.1084/jem.189.7.1149
Colonna, 1997, A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells, J Exp Med, 186, 1809, 10.1084/jem.186.11.1809
Navarro, 1999, The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells, Eur J Immunol, 29, 277, 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4
Cantoni, 1998, p49, a putative HLA class I-specific inhibitory NK receptor belonging to the Ig superfamily, Eur J Immunol, 28, 1980, 10.1002/(SICI)1521-4141(199806)28:06<1980::AID-IMMU1980>3.0.CO;2-F
Colonna, 1998, Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules, J Immunol, 160, 3096, 10.4049/jimmunol.160.7.3096
Rajagopalan, 1999, A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells, J Exp Med, 189, 1093, 10.1084/jem.189.7.1093
Braud, 1998, HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, Nature, 391, 795, 10.1038/35869
Borrego, 1998, Recognition of human histocompatibility leucocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis, J Exp Med, 187, 813, 10.1084/jem.187.5.813
Lee, 1998, HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A, Proc Natl Acad Sci USA, 95, 5199, 10.1073/pnas.95.9.5199
Khalil-Daher I, Riteau B, Menier C, Sedlik C, Paul P, Dausset J, Carosella ED, Rouas-Freiss N: Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 43:175, 1998.
Le Gal FA, Riteau B, Sedlick C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N: HLA-G mediated-inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11:1351, 1999.
McMaster, 1995, Human placental HLA-G expression is restricted to differentiated cytotrophoblasts, J Immunol, 154, 3771, 10.4049/jimmunol.154.8.3771
Loke, 1997, Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody, Tissue Antigens, 50, 135, 10.1111/j.1399-0039.1997.tb02852.x
Schust, 1996, Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells, J Immunol, 157, 3375, 10.4049/jimmunol.157.8.3375
Bensussan, 1995, Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody, Proc Natl Acad Sci USA, 92, 10292, 10.1073/pnas.92.22.10292
Crisa, 1997, Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts, J Exp Med, 186, 289, 10.1084/jem.186.2.289
Blaschitz, 1997, Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G, Eur J Immunol, 27, 3380, 10.1002/eji.1830271237
Houlihan, 1995, The human amnion is a site of MHC class Ib expression, J Immunol, 154, 5665, 10.4049/jimmunol.154.11.5665
McMaster, 1998, HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation, J Immunol, 160, 5922, 10.4049/jimmunol.160.12.5922
Jurisicova, 1996, HLA-G expression during preimplantation human embryo development, Proc Natl Acad Sci USA, 93, 161, 10.1073/pnas.93.1.161
Yang, 1996, Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ, J Immunol, 156, 4224, 10.4049/jimmunol.156.11.4224
Amiot, 1998, HLA-G class I gene expression in normal and malignant hematopoietic cells, Hum Immunol, 59, 524, 10.1016/S0198-8859(98)00041-X
Moreau, 1999, IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes, Int Immunol, 11, 803, 10.1093/intimm/11.5.803
Paul, 1998, HLA-G expression in melanoma, Proc Natl Acad Sci USA, 95, 4510, 10.1073/pnas.95.8.4510
Paul, 1999, Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies, Cancer Res, 59, 1954
Fukushima, 1998, Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells, Int J Mol Med, 2, 349
Pangault, 1999, HLA-G protein expression is not induced during malignant transformation, Tissue Antigen, 53, 335, 10.1034/j.1399-0039.1999.530403.x
Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED: Implication of HLA-G molecule in heart graft acceptance. Lancet 355:2138, 2000.
Houlihan, 1992, Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver, J Immunol, 149, 668, 10.4049/jimmunol.149.2.668
Moreau, 1995, Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term, Comptes Rendus de l Academie des Sciences - Serie Iii, Sciences de la Vie, 318, 837
Castro, 1998, Lack of HLA-G soluble isoformes in Graves-Basedow thyrocytes and complete cDNA sequence of the HLA-G∗01012 allele, Eur J Immunogenet, 25, 311, 10.1046/j.1365-2370.1998.00102.x
Gomez-Casado, 1999, Detection of HLA-E and -G alleles for population and disease studies, Cell Mol Life Sci, 56, 356, 10.1007/s000180050436
Chomczynski P, Sacchi N: Single step method of RNA isolotion by acid guanidinium thiocyanate phenol chloroforme extraction. Anal Biochem 162:156, 1987.
Giacomini P, Giorda E, Fraioli R, Nicotra MR, Vitale N, Setini A, Delfino L, Morabito A, Benevolo M, Venturo I, Mottolese MF, Ferrara GB, Natali PG: Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines. Cancer Res 59:2657, 1999.